Skip to main content

Advertisement

Log in

Diagnosis and therapy for neurogenic bladder dysfunctions in multiple sclerosis patients

  • Urinary Dysfunctions
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Neurogenic lower urinary tract dysfunctions are common in patients with multiple sclerosis and for most of them urinary dysfunction has the most negative impact on their social life. No correlation exists between clinical urinary symptoms and urodynamic patterns. Abnormal urodynamic patterns may be present in asymptomatic patients. Both clinical and urodynamic findings may change during the course of the illness. Early diagnostic approach and scheduled follow-ups are mandatory in order to prevent upper urinary tract complications and improve quality of life (QoL).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Litwiller SE, Frohman EM, Zimmern PE (1999) Multiple sclerosis and the urologist. J Urol 161:743–757

    Article  PubMed  CAS  Google Scholar 

  2. Hinson JL, Boone TB (1996) Urodynamics and multiple sclerosis. Urol Clin North Am 23:475–481

    Article  PubMed  CAS  Google Scholar 

  3. DasGupta R, Fowler CJ (2002) Sexual and urological dysfunction in multiple sclerosis: better understanding and improved therapies. Curr Opin Neurol 15:271–278

    Article  PubMed  Google Scholar 

  4. Wheeler JS, Siroky MB, Pavlakis AJ et al (1983) The changing neurourologic pattern of multiple sclerosis. J Urol 130:123

    Google Scholar 

  5. Bemelmans BL, Hommes OR, Van Kerrebroeck PE et al (1991) Evidence for early lower urinary tract dysfunction in clinically silent multiple sclerosis. J Urol 145:1219–1224

    PubMed  CAS  Google Scholar 

  6. Rickwood AM (2002) Assessment and conservative management of the neuropathic bladder. Semin Pediatr Surg 11:108–119

    Article  PubMed  CAS  Google Scholar 

  7. Wyndaele JJ, Castro D, Madersbacher H et al (2005) Neurologic urinary and faecal incontinence. In: Abrams P, Cardozo L, Khoury S, Wein A (eds) Incontinence. Health Publications, Plymouth, 1061–1162

    Google Scholar 

  8. Wein AJ (1998) Pathophysiology and categorization of voiding dysfunction. In: Walsh PC, Retik AB, Vaughan Jr ED, Wein AJ (eds) Campbell’s urology, 7th Edn. WB Saunders, Philadelphia, 917–926

    Google Scholar 

  9. Krane RJ, Siroky MB (1979) Classification of neuro-urologic disorders. In: Krane RJ, Siroky MB (eds) Clinical neuro-urology. Little Brown, Boston, 143–158

    Google Scholar 

  10. Stöhrer M, Goepel M, Kondo A et al (1999) The standardization of terminology in neurogenic lower urinary tract dysfunction with suggestions for diagnostic procedures. International Continence Society Standardization Committee. Neurourol Urodyn 18:139–158

    Google Scholar 

  11. Weld KJ, Dmochowski RR (2000) Association of level of injury and bladder behavior in patients with posttraumatic spinal cord injury. Urology 55:490–494

    Article  PubMed  CAS  Google Scholar 

  12. Chancellor MB, Anderson RU, Boone TB (2006) Pharmacotherapy for neurogenic detrusor overactivity. Am J Phys Med Rehabil 85:536–545

    Article  PubMed  Google Scholar 

  13. Diokno A, Ingber M (2006) Oxybutynin in detrusor overactivity. Urol Clin N Am 33:439–445

    Article  Google Scholar 

  14. Buyse G, Waldeck K, Verpoorten C et al (1998) Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism. J Urol 160:892–896

    Article  PubMed  CAS  Google Scholar 

  15. Di Stasi SM, Giannantoni A, Navarra P et al (2001) Intravesical oxybutynin: mode of action assessed by passive diffusion and electromotive administration with pharmacokinetics of oxybutynin and N-desethyl oxybutynin. J Urol 166:2232–2236

    Article  PubMed  Google Scholar 

  16. Christ KF, Kornhuber HH (1980) Treatment of neurogenic bladder dysfunction in multiple sclerosis by ultrasound-controlled bladder training. Arch Psychiatr Nervenkr 228:191–195

    Article  PubMed  CAS  Google Scholar 

  17. Yamanishi T, Yasuda K, Kamai T et al (2004) Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor. Int J Urol 11:88–96

    Article  PubMed  CAS  Google Scholar 

  18. De Ridder D, Vermeulen C, Ketelaer P et al (1999) Pelvic floor rehabilitation in multiple sclerosis. Acta Neurol Belg 99:61–64

    PubMed  Google Scholar 

  19. Ishigooka M, Hashimoto T, Hayami S et al (1996) Electrical pelvic floor stimulation: a possible alternative treatment for reflex urinary incontinence in patients with spinal cord injury. Spinal Cord 34:411–415

    PubMed  CAS  Google Scholar 

  20. McClurg D, Ashe RG, Marshall K, Lowe-Strong AS (2006) Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot study. Neurourol Urodyn 25:337–348

    Article  PubMed  CAS  Google Scholar 

  21. Primus G, Kramer G (1996) Maximal external electrical stimulation for treatment of neurogenic or non neurogenic urgency and/or urge incontinence. Neurourol Urodyn 15:187–194

    Article  PubMed  CAS  Google Scholar 

  22. Amarenco G, Ismael SS, Even-Schneider A et al (2003) Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder. J Urol 169:2210–2215

    Article  PubMed  CAS  Google Scholar 

  23. Hagerty JA, Richards I, Kaplan WE (2007) Intravesical electrotherapy for neurogenic bladder dysfunction: a 22-year experience. J Urol 178:1680–1683

    Article  PubMed  Google Scholar 

  24. Del Popolo G, Filocamo MT, Li Marzi V et al (2007) Neurogenic detrusor overactivity treated with English botulinum toxin A: 8-year experience of one single centre. Eur Urol 53:1013–1019

    Article  PubMed  CAS  Google Scholar 

  25. Petit H, Wiart L, Gaujard E et al (1998) Botulinum: a toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease. Spinal Cord 36:91–94

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giulio Del Popolo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Del Popolo, G., Panariello, G., Del Corso, F. et al. Diagnosis and therapy for neurogenic bladder dysfunctions in multiple sclerosis patients. Neurol Sci 29 (Suppl 4), 352–355 (2008). https://doi.org/10.1007/s10072-008-1042-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-008-1042-y

Keywords

Navigation